XML 54 R40.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS' EQUITY (Tables)
 6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
Three Months Ended
June 30,		Six Months Ended
June 30,
(in thousands)2025202420252024
Cost of revenue
$7,288 $7,092 $15,111 $13,664 
Selling and marketing
14,378 13,564 30,159 27,452 
Research and development
7,490 7,825 15,875 15,471 
General and administrative
7,574 7,743 17,010 14,418 
$36,730 $36,224 $78,155 $71,005 
Income tax benefit
$(566)$(554)$(1,153)$(865)
Schedule of Stock-based Compensation Expense Grants
Six Months Ended
June 30, 2025
(in thousands)
Quantity
Total Fair Value
Restricted stock units (1)
1,963$76,969 
Non-qualified stock options
3,152 $49,730 
Performance stock options (2)
1,346 $34,924 
Common stock
1$52 
(1) Includes units issued when employees elect to receive 50% of the employee’s target incentive compensation under the Company’s Corporate Incentive Compensation Plan (the “CICP”) in the form of RSUs instead of cash.
(2) Performance stock options allow the holder to purchase a specified number of Common Stock shares at an exercise price equal to or greater than the shares' fair market value at the grant date. The performance stock options granted in the six months ended June 30, 2025 vest quarterly over two years, beginning after the achievement of specific performance conditions. The options expire ten years from the grant date.